Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 299

3.

Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.

Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M.

J Urol. 2000 Apr;163(4):1144-8; discussion 1148-9.

PMID:
10737484
5.
6.

Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer.

Fowler JE Jr, Bigler SA, Miles D, Yalkut DA.

J Urol. 2000 Mar;163(3):813-8.

PMID:
10687983
7.

Clinical usefulness of free PSA in early detection of prostate cancer.

Luboldt HJ, Swoboda A, Börgermann C, Fornara P, Rübben H; Early Detection Project Group of the German Society of Urology.

Onkologie. 2001 Feb;24(1):33-7.

PMID:
11441278
8.

Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values.

Keetch DW, Catalona WJ, Smith DS.

J Urol. 1994 Jun;151(6):1571-4.

PMID:
7514690
9.
10.

Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen.

Morgan TO, McLeod DG, Leifer ES, Murphy GP, Moul JW.

Urology. 1996 Dec;48(6A Suppl):76-80.

PMID:
8973705
11.
12.

Significance of serum free prostate specific antigen in the screening of prostate cancer.

Higashihara E, Nutahara K, Kojima M, Okegawa T, Miura I, Miyata A, Kato M, Sugisaki H, Tomaru T.

J Urol. 1996 Dec;156(6):1964-8. Review.

PMID:
8911366
13.

Prostate carcinoma screening in the county of Tyrol, Austria: experience and results.

Reissigl A, Horninger W, Fink K, Klocker H, Bartsch G.

Cancer. 1997 Nov 1;80(9):1818-29.

PMID:
9351555
14.

Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4-10 ng/ml.

Martínez-Piñeiro L, García Mediero JM, González Gancedo P, Tabernero A, Lozano D, López-Tello JJ, Alonso-Dorrego JM, Núñez C, Picazo ML, Madero R, De La Peña JJ.

World J Urol. 2004 Jun;22(2):124-31. Epub 2004 Feb 20.

PMID:
14986047
15.

Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL.

Babaian RJ, Fritsche H, Ayala A, Bhadkamkar V, Johnston DA, Naccarato W, Zhang Z.

Urology. 2000 Dec 20;56(6):1000-6.

PMID:
11113747
17.

Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.

Martínez-Piñeiro L, Tabernero A, Contreras T, Madero R, Lozano D, López-Tello J, Alonso-Dorrego JM, Picazo ML, González Gancedo P, Martínez-Piñeiro JA, de La Peña JJ.

Eur Urol. 2000 Mar;37(3):289-96.

PMID:
10720854
18.

Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.

Törnblom M, Norming U, Adolfsson J, Becker C, Abrahamsson PA, Lilja H, Gustafsson O.

Urology. 1999 May;53(5):945-50.

PMID:
10223488
19.

The percentage of free prostatic-specific antigen is also useful in men with normal digital rectal examination and serum prostatic-specific antigen between 10.1 and 20 ng/ml.

Morote J, Trilla E, Esquena S, Serrallach F, Abascal JM, Muñoz A, Id M'Hammed Y, de Torres IM.

Eur Urol. 2002 Oct;42(4):333-7.

PMID:
12361897

Supplemental Content

Support Center